PHASTAR announced that Jennifer Rogers, PhD, has been appointed Head of Statistical Research. Professor Rogers brings to PHASTAR a broad portfolio of achievement, particularly in the development of clinical trial methodologies. Her areas of expertise include survival analysis, the analysis of recurrent events and joint modeling strategies that combine the two focus areas.
 
In her new role at PHASTAR, Professor Rogers will direct the statistical research strategy helping the company stay at the cutting edge of new methodological advances. She will provide leadership and advice to current and potential customers, with a focus on biotech and pharma companies. Additionally, Rogers will continue giving conference presentations, talking all things statistics in schools, theaters, and representing the statistical community on television and radio.  
 
Professor Rogers began her academic career at Lancaster University where she earned her BSc and MSc before moving to the University of Warwick to complete her PhD. In 2013, she was awarded a NIHR Post-Doctoral Fellowship for her project, “Analysis of Recurrent Events in Clinical Trials” and during this time moved on to the University of Oxford. At Oxford she was named to a new created role of Director of Statistical Consultancy Services and was responsible for creating and leading a new consultancy unit within the Department of Statistics. 
 
In addition to her academic credentials, Professor Rogers is an active member of the Royal Statistical Society, currently sitting on the RSS Council and being the Society’s Vice President for External Affairs. She was also appointed President of the British Science Association Mathematical Sciences Section for 2018, giving a keynote speech at the British Science Festival, and was the London Mathematical Society Popular Lecturer for 2018. 
 
“We are extremely pleased to have someone with Professor Roger’s credentials heading up our statistical research group, demonstrating PHASTAR’s commitment to statistical excellence,” said Kevin Kane, CEO and Founder of PHASTAR. “She is highly regarded and a recognized expert in the field of clinical trial strategies in addition to having an enviable academic record, including being named as an Associate Professor in Statistics at Oxford University in January 2019.”